These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5328901)

  • 41. The suppression of Plasmodium falciparum and Plasmodium vivax parasitaemias by a dapsone-pyrimethamine combination.
    Segal HE; Pearlman EJ; Thiemanun W; Castaneda BF; Ames CW
    J Trop Med Hyg; 1973 Nov; 76(11):285-90. PubMed ID: 4586093
    [No Abstract]   [Full Text] [Related]  

  • 42. The chemotherapy of rodent malaria, XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity.
    Peters W
    Ann Trop Med Parasitol; 1975 Jun; 69(2):155-71. PubMed ID: 1098584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation of antimalarial drugs in a region with a high prevalence of chloroquine-resistant Plasmodium falciparum (Burundi, Central Africa)].
    Coosemans MH; Nguyen-Dinh P
    Ann Soc Belg Med Trop; 1985; 65 Suppl 2():115-21. PubMed ID: 3907529
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of acute falciparum malaria with diaphenylsulfone in North-East Tanzania.
    Laing AB
    J Trop Med Hyg; 1965 Oct; 68(10):251-3. PubMed ID: 5839003
    [No Abstract]   [Full Text] [Related]  

  • 45. Study of Plasmodium falciparum resistance to 4-Aminoquinolines (Chloroquine) in Sabah, Malaysia.
    Maqsudur Rahman KM
    J Trop Med Hyg; 1980 Dec; 83(6):259-64. PubMed ID: 7003166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Supplemental sulfone (dapsone) therapy. Use in treatment of chloroquine-resistant falciparum malaria.
    Sheehy TW; Reba RC; Neff TA; Gaintner JR; Tigertt WD
    Arch Intern Med; 1967 Jun; 119(6):561-6. PubMed ID: 5338485
    [No Abstract]   [Full Text] [Related]  

  • 47. Responsibility for failure of sulphonamides in falciparum malaria; host or parasite?
    Clyde DF
    Trans R Soc Trop Med Hyg; 1972; 66(5):806-7. PubMed ID: 4567255
    [No Abstract]   [Full Text] [Related]  

  • 48. Antimalarial effect of diaphenylsulfone and three sulfonamides among semi-immune Africans.
    Clyde DF
    Am J Trop Med Hyg; 1967 Jan; 16(1):7-10. PubMed ID: 6021731
    [No Abstract]   [Full Text] [Related]  

  • 49. Suggested new mechanisms of antimalarial action for DDS involving inhibition of glucose utilization by the intraerythrocytic parasite.
    Cenedella RJ; Jarrell JJ
    Am J Trop Med Hyg; 1970 Jul; 19(4):592-8. PubMed ID: 5425495
    [No Abstract]   [Full Text] [Related]  

  • 50. Prophylaxis of malaria in man using the sulfones DFD and DDS alone and with chloroquine.
    Clyde DF; Rebert CC; McCarthy VC; Miller RM
    Mil Med; 1971 Nov; 136(11):836-41. PubMed ID: 5005277
    [No Abstract]   [Full Text] [Related]  

  • 51. Pathologic physiology and chemotherapy of Plasmodium berghei. I. Suppression of parasitemia by sulfones and sulfonamides in mice.
    Aviado DM
    Exp Parasitol; 1967 Feb; 20(1):88-97. PubMed ID: 6026226
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of PABA on chloroquine resistance in Plasmodium berghei yoelii.
    Carter R
    Nature; 1972 Jul; 238(5359):98-9. PubMed ID: 4557790
    [No Abstract]   [Full Text] [Related]  

  • 53. Sulphonamide resistance induced in malaria parasites by milk diet given to host animals.
    Nowell F
    Trans R Soc Trop Med Hyg; 1972; 66(2):376-7. PubMed ID: 5048874
    [No Abstract]   [Full Text] [Related]  

  • 54. [DIAPHENYLSULFONE; bis(4-aminophenyl) sulfone; 4,4-diamino diphenyl-sulfone].
    Ann Pharm Fr; 1959 Mar; 17():228-31. PubMed ID: 13856630
    [No Abstract]   [Full Text] [Related]  

  • 55. [Drug analysis by polarographic methods. 26. Polarographic determination (DPP) of the antileprosy agent diaphenylsulfone (dapsone)].
    Oelschläger H; Modrack G
    Arch Pharm (Weinheim); 1986 Jan; 319(1):10-4. PubMed ID: 3964034
    [No Abstract]   [Full Text] [Related]  

  • 56. The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency.
    Degowin RL; Eppes RB; Powell RD; Carson PE
    Bull World Health Organ; 1966; 35(2):165-79. PubMed ID: 5297001
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of malaria infection.
    Contacos PG
    Bull N Y Acad Med; 1969 Oct; 45(10):1077-85. PubMed ID: 5259668
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical testing of new antimalarial compounds.
    Canfield CJ; Rozman RS
    Bull World Health Organ; 1974; 50(3-4):203-12. PubMed ID: 4613503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of dihydropteroate synthetase from Escherichia coli by sulfones and sulfonamides.
    McCullough JL; Maren TH
    Antimicrob Agents Chemother; 1973 Jun; 3(6):665-9. PubMed ID: 4597736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. N-hydroxylation of 4,4'-diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and humans.
    Uehleke H; Tabarelli S
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(1):55-68. PubMed ID: 4145470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.